Literature DB >> 16546949

Immediate open reduction and internal fixation in open ankle fractures.

Deepak Joshi1, Davindar Singh, Juned Ansari, Yadu Lal.   

Abstract

In this prospective study, 30 patients (28 men and 2 women) with open ankle fractures were treated with early debridement and immediate stable internal fixation after anatomical reduction to achieve better functional results after early mobilization. The procedure was performed an average of 8 hours (range, 6-15 hours) after injury. According to the classification system of Gustilo and Anderson, 11 fractures (37%) were grade I, 12 (40%) were grade II, 5 (17%) were grade IIIA, and 2 (7%) were grade IIIB. Six complications occurred: four patients had superficial skin necrosis and two had loss of reduction, resulting in residual ankle stiffness. Twenty patients had excellent results, eight had good results, and two had fair results according to the modified criteria of Ketenjian and Shelton. We found that immediate debridement, anatomical reduction, and internal fixation of open ankle fractures leads to better functional results, especially in grade I and grade II injuries.

Entities:  

Mesh:

Year:  2006        PMID: 16546949     DOI: 10.7547/0960120

Source DB:  PubMed          Journal:  J Am Podiatr Med Assoc        ISSN: 1930-8264


  3 in total

1.  [Surgical treatment of ankle fractures as an outpatient procedure. A safe and resource-efficient concept?].

Authors:  S Weckbach; M A Flierl; M Huber-Lang; F Gebhard; P F Stahel
Journal:  Unfallchirurg       Date:  2011-10       Impact factor: 1.000

Review 2.  Evidence-based treatment of open ankle fractures.

Authors:  Caroline C C Hulsker; Sanne Kleinveld; Chris B L Zonnenberg; Mike Hogervorst; Michel P J van den Bekerom
Journal:  Arch Orthop Trauma Surg       Date:  2011-06-29       Impact factor: 3.067

3.  Open ankle fractures are associated with complications and reoperations.

Authors:  Natasha M Simske; Megan A Audet; Chang-Yeon Kim; Heather A Vallier
Journal:  OTA Int       Date:  2019-11-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.